Missed opportunities for HIV diagnosis among those at risk

June 27, 2018

(HealthDay)—Considerable numbers of men who have sex with men (MSM) and persons who inject drugs (PWID) who are unaware of their HIV infection report missed opportunities for diagnosis, according to a research letter published online June 26 in the Journal of the American Medical Association.

Cyprian Wejnert, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estimated the percentages of MSM and PWID who were unaware of their HIV infection and had missed opportunities for testing and diagnosis in clinical settings. Data were included for 9,105 MSM and 19,357 PWID.

The researchers found that 22 percent of MSM and 8 percent of PWID had a positive result for HIV infection. Of the participants who were HIV positive, 8 and 12 percent, respectively, were unaware of their infection. Among those who were unaware, 81 percent of MSM and 65 percent of PWID reported having visited a clinician in the past year. In that time, 43 and 24 percent, respectively, reported being offered an HIV test. Overall, 44 percent of unaware MSM and 77 percent of unaware PWID reported not being tested for HIV test in the past year; 52 and 45 percent of those not tested in the past year reported not having been offered an HIV test at a clinic visit.

"Eliminating missed opportunities for HIV testing and diagnosis in health care settings may reduce HIV transmission, especially among high-risk groups," the authors write.

Explore further: New perspectives on risk of HIV and hepatitis among injecting drug users

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

New perspectives on risk of HIV and hepatitis among injecting drug users

October 24, 2017
Reviews of the global prevalence of injecting drug use and of interventions to prevent the spread of blood-borne viruses among people who inject drugs paint a worrying picture.

Cutting HIV in drug users can benefit others' AIDS mortality

March 26, 2014
(HealthDay)—Efforts to curb HIV transmission among people who inject drugs (PWID) and non-injecting drug users (NIDUs) may reduce AIDS and AIDS-related mortality among heterosexuals, according to a study published in the ...

Emerging HIV epidemics among people who inject drugs in the Middle East and North Africa

June 19, 2014
HIV epidemics are emerging among people who inject drugs in several countries in the Middle East and North Africa. Though HIV infection levels were historically very low in the Middle East and North Africa, substantial levels ...

Researchers examine the relationship between drug injection risk behaviors and immune activation

April 13, 2017
The use of heroin and other illicit drugs has been shown to trigger a response from the body's immune system. Consequently, high levels of immune activation (inflammation)—that is associated with the progression of chronic ...

Severe liver damage in mid/late-adulthood among PWID with chronic HCV

October 5, 2015
The Hepatitis C virus (HCV) infection is a chronic blood-borne viral infection that affects an estimated 160 million people, or 2-3% of the population world-wide. Alarmingly, chronic HCV infection accounts for one-quarter ...

Lack of recent health care tied to unawareness of diabetes

March 21, 2017
(HealthDay)—Factors that are associated with being unaware of diabetes include not receiving health care in the past year, while a family history of diabetes and hospitalizations in the past year are factors associated ...

Recommended for you

FRESH program combines basic science with social benefits for women at risk of HIV

September 14, 2018
A program established by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from ...

New study finds HIV outbreak in Indiana could have been prevented

September 13, 2018
An HIV outbreak among people who inject drugs in Indiana from 2011 to 2015 could have been avoided if the state's top health and elected officials had acted sooner on warnings, a new study by the Yale School of Public Health ...

Largest study of 'post-treatment controllers' reveals clues about HIV remission

September 13, 2018
Most HIV patients need to take daily anti-retroviral therapy—if they suspend treatment, HIV will rebound within 3-4 weeks. But clinical trials have revealed that a small fraction of patients can stop taking medications ...

Very few sexually active gay and bisexual men use prophylactic drug to prevent HIV transmission, study finds

September 12, 2018
Only 4 percent of sexually active gay and bisexual men in the United States use Truvada, a highly effective medication used to prevent the transmission of HIV, according to the results of a first-of-its-kind study.

Special antibodies could lead to HIV vaccine

September 10, 2018
Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the ...

Researchers date 'hibernating' HIV strains

September 5, 2018
Researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) and Simon Fraser University (SFU), in partnership with University of British Columbia (UBC) and Western University, have developed a novel way for dating "hibernating" ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.